SCHEMBL13482134

SCHEMBL13482134

COC(=O)CCCN(C)c1nccnc1C(=O)OC

nearest known ligand 0.41

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
TMPRSS15 P98073 4/20 0.41
TSHR P16473 2/20 0.39
LTA4H P09960 2/20 0.38
MEN1 O00255 3/20 0.38
KMT2A Q03164 3/20 0.38
ALDH1A1 P00352 2/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
LMNA P02545 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
RAB9A P51151 1/20 0.36
CYP1A2 P05177 1/20 0.35
PDE3B Q13370 4/20 0.34
PDE3A Q14432 4/20 0.34
P2RY12 Q9H244 3/20 0.34
GBA1 P04062 1/20 0.34
NPSR1 Q6W5P4 1/20 0.34
PDE2A O00408 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13482930 0.90 FFAR4 (0.41) TMPRSS15TSHRLTA4HSMN1; SMN2L3MBTL1
SCHEMBL29133980 0.72 L3MBTL1 (0.41) TSHRMEN1KMT2AALDH1A1SMN1; SMN2
SCHEMBL29133916 0.70 KMT2A (0.45) TSHRMEN1KMT2AALDH1A1SMN1; SMN2
SCHEMBL71518 0.70 NPSR1 (0.59) TSHRALDH1A1SMN1; SMN2L3MBTL1NPSR1
SCHEMBL8708337 0.69 L3MBTL1 (0.36) ALDH1A1SMN1; SMN2L3MBTL1CYP1A2NPSR1
SCHEMBL25408977 0.67 TMPRSS15 (0.60) TMPRSS15TSHRLTA4HMEN1KMT2A
SCHEMBL14430424 0.66 MEN1 (0.71) TSHRLTA4HMEN1KMT2AALDH1A1
SCHEMBL713902 0.66 TSHR (0.64) TSHRLTA4HMEN1KMT2AALDH1A1
SCHEMBL30826512 0.66 LTA4H (0.52) TSHRLTA4HMEN1KMT2AALDH1A1
SCHEMBL23888774 0.66 NPSR1 (0.48) TSHRALDH1A1SMN1; SMN2L3MBTL1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7659281-B2 HMG-CoA reductase inhibitors BRISTOL-MYERS SQUIBB COMPANY (US) 2010-02-09 US disclosed
US-7659281-B2 HMG-CoA reductase inhibitors BRISTOL-MYERS SQUIBB COMPANY (US) 2010-02-09 US disclosed
US-20070249583-A1 HMG-CoA reductase inhibitors BRISTOL-MYERS SQUIBB COMPANY 2007-10-25 US disclosed
US-20070249583-A1 HMG-CoA reductase inhibitors BRISTOL-MYERS SQUIBB COMPANY 2007-10-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070249583-A1 HMG-CoA reductase inhibitors HMGCR, LDLR, PCSK9 TMPRSS15 599/4885TSHR 2006/4885LTA4H 833/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.